Ajanta Pharma Ltd. (AJANTPHARM) Share Price Hits Fresh 52-Week High

Ajanta Pharma Ltd. Share Price stood at Rs 3,709.15, up 0.93% today, after hitting a fresh 52-week high of Rs 3,722.15. Market capitalisation was Rs 45,924.32 crore.

Ajanta Pharma Ltd. Share Price was at Rs 3,709.15 on 17 August 2026 at 9:58 AM IST, up Rs 34 or 0.93% from the previous close of Rs 3,675.15, after the stock touched a fresh 52-week high of Rs 3,722.15 in today’s session. With a market capitalisation of Rs 45,924.32 crore and turnover of Rs 1.59 crore so far, the stock has moved into focus in today’s Stock Market Today screens and among 52 Week High Stocks being tracked by market participants.

The verified data confirms the price event clearly: the stock opened at Rs 3,675.15, traded between Rs 3,650.20 and Rs 3,722.15, and remained near its one-year high early in the session. That makes this Ajanta Pharma Ltd. Share Price Today move relevant not because of any confirmed company-specific trigger in the supplied data, but because a fresh yearly high often brings additional attention to price action, valuation and relative positioning within the Healthcare sector.

For readers tracking Ajanta Pharma Ltd. Stock News, the immediate question is not only what happened today, but also how the current valuation and profitability profile compare with peers and the wider sector benchmark. This Univest analysis focuses on those verified data points and on what investors may want to monitor next.

Ajanta Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,709.15
Previous Close	Rs 3,675.15
Today's Change	+Rs 34 (+0.93%)
Day Open	Rs 3,675.15
Fresh 52-Week High	Rs 3,722.15
Day Low	Rs 3,650.2
Current Volume	4,294
Turnover	Rs 1.59 crore
Market Capitalisation	Rs 45,924.32 crore

Ajanta Pharma Ltd. (AJANTPHARM) traded at Rs 3,709.15. versus the previous close of Rs 3,675.15, a rise of 0.93%. The stock opened at Rs 3,675.15, reached Rs 3,722.15, touched Rs 3,650.2. Reported volume was 4,294.

Ajanta Pharma Ltd. Share Price Today moved into a fresh 52-week peak zone after the stock opened at Rs 3,675.15, matched the previous close at the open, and then climbed to Rs 3,722.15 before easing slightly to Rs 3,709.15. The session range and the move above the prior one-year ceiling put the stock firmly in focus among today’s market movers.

From the previous close of Rs 3,675.15, the stock was higher by Rs 34, translating into a 0.93% gain. The day’s low stood at Rs 3,650.20, while the intraday high also marked the fresh 52-week high at Rs 3,722.15. Because the stock remained close to that high after touching it, the price action suggests sustained attention rather than an isolated print at the top of the range.

Volume stood at 4,294 shares, with turnover at Rs 1.59 crore. On its own, that confirms trading activity around the breakout to a 52-week high, though the supplied data does not establish a company-specific catalyst behind the move. For traders and long-term trackers alike, the immediate takeaway from this Ajanta Pharma Ltd. Share Price Update is that the stock has entered a fresh price discovery zone on a one-year basis.

That naturally shifts the discussion from the day’s move to the bigger question: whether the current Ajanta Pharma Ltd. Stock Analysis is being supported by underlying financial metrics and how those numbers compare with the broader Healthcare basket.

Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 45,924.32 crore
P/E Ratio	184.72x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Ajanta Pharma Ltd. was valued at a P/E ratio of 184.72x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	184.72x
Benchmark Median P/E	21.1x
Benchmark Average P/E	49.38x
Benchmark P/E Range	0x to 1,603.4x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.71%
Company ROCE	-0.26%
Benchmark Median ROCE	13.15%
Company Market Capitalisation	Rs 45,924.32 crore
Benchmark Median Market Cap	Rs 135.27 crore

Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare.

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	184.72	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	68.16	6.74	18.65	22.17
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	46.15	1.77	-0.78	8.31
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,612.26	34.27	7.07	-2.6	16.92
Fredun Pharmaceuticals Ltd.	FREDUN	2,559.68	58.41	8.73	11.42	13.15

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 45,924.32 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Ajanta Pharma Ltd.

This stock is on investors’ radar because the verified data combines a fresh 52-week high with a valuation profile that stands out sharply against sector and peer benchmarks. For anyone tracking Ajanta Pharma Ltd. Share Price Live, these are the main watchpoints right now.

• Fresh price event: The stock touched a new 52-week high of Rs 3,722.15 and was still at Rs 3,709.15, up 0.93%, near that peak.
• Session range: The day’s movement between Rs 3,650.20 and Rs 3,722.15 shows active intraday price action around the one-year high.
• Trading activity: Volume of 4,294 shares and turnover of Rs 1.59 crore confirm participation around the move.
• Valuation focus: P/E at 184.72 is above the Healthcare median of 21.10 and average of 49.38.
• Profitability contrast: ROE of -2.89% and ROCE of -0.26% are below the sector medians of 10.71% and 13.15%.
• Scale advantage: Market capitalisation of Rs 45,924.32 crore is much larger than the benchmark median of Rs 135.27 crore and average of Rs 456.49 crore.

About Ajanta Pharma Ltd.

Ajanta Pharma Ltd. is being evaluated here within the Healthcare sector. The supplied peer set links the company to the broader Pharmaceuticals & Drugs context used for comparison, while one peer in the sector snapshot belongs to Hospital & Healthcare Services, showing that the benchmark itself is sector-wide rather than limited to a single sub-industry.

That distinction matters for investors reading Ajanta Pharma Ltd. Company News and Ajanta Pharma Ltd. Share News. A same-sector comparison can be useful for identifying broad valuation and profitability positioning, but it can also include businesses with different operating models inside Healthcare. In this article, Univest therefore uses the sector benchmark for broad context and the supplied peer list for closer listed comparisons.

As a result, the main role of this section is factual: Ajanta Pharma Ltd. is being tracked as part of India’s Healthcare space, and today’s attention is being driven by a fresh one-year high in the stock rather than by any separately verified business update in the supplied data. For readers scanning Stocks in News and NSE News or BSE News style coverage, that distinction helps separate the confirmed price event from any unsupported narrative.

Track Ajanta Pharma Ltd. Share Price on Univest

Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers tracking Ajanta Pharma Ltd. Share Price can use Univest to follow live price moves, 52-week levels, market capitalisation, valuation ratios and sector context in one place. Univest also helps users monitor how the stock is positioned versus Healthcare benchmarks and listed peers as new market data comes in.

For anyone following Ajanta Pharma Ltd. Latest News, Ajanta Pharma Ltd. NSE updates, Ajanta Pharma Ltd. BSE coverage or broader Market News, the key benefit is context. A stock reaching a fresh yearly high often becomes part of Top Gainers Today, Breakout Stocks or Momentum Stocks conversations, but the more useful analysis comes from checking whether price action is aligned with valuation, profitability and relative positioning. That is the lens Univest applies here.

Frequently Asked Questions

What is Ajanta Pharma Ltd. Share Price today?

Ans. Ajanta Pharma Ltd. Share Price was Rs 3,709.15 on 17 August 2026 at 9:58 AM IST. The stock was up Rs 34, or 0.93%, from the previous close of Rs 3,675.15.

Did Ajanta Pharma Ltd. hit a 52-week high today?

Ans. Yes, the stock touched a fresh 52-week high of Rs 3,722.15 during the session. It then traded at Rs 3,709.15, staying close to that yearly peak early in the day.

Why is Ajanta Pharma Ltd. Share Price rising today?

Ans. The supplied data confirms that the stock rose 0.93% and reached a fresh 52-week high. It shows the price event clearly, but it does not establish a separate company-specific catalyst behind the move.

What were the day high, day low and opening price?

Ans. Ajanta Pharma Ltd. opened at Rs 3,675.15, the same as its previous close. During the session, it traded between a low of Rs 3,650.20 and a high of Rs 3,722.15.

What is the market capitalisation of Ajanta Pharma Ltd.?

Ans. The company’s market capitalisation stood at Rs 45,924.32 crore. That is far above the Healthcare sector benchmark median of Rs 135.27 crore and average of Rs 456.49 crore in the supplied dataset.

How is Ajanta Pharma Ltd. valued on P/E and P/B?

Ans. The stock trades at a P/E ratio of 184.72 and a P/B ratio of 0.45. In the sector snapshot, the median P/E is 21.10 and median P/B is 1.90. The company trades at a P/E ratio of 184.72x.

What do the ROE and ROCE figures show?

Ans. ROE is -2.89% and ROCE is -0.26%, indicating weaker profitability than the sector benchmark. The Healthcare median ROE is 10.71%, while the median ROCE stands at 13.15%. ROE stands at -2.89%.

How does Ajanta Pharma Ltd. compare with the supplied peers?

Ans. Ajanta Pharma Ltd. has a market cap of Rs 45,924.32 crore, much larger than the displayed peers. Its P/E of 184.72 is also above most peers, while ROE and ROCE are comparatively weaker.

What should investors monitor next in Ajanta Pharma Ltd. Stock News?

Ans. Investors may track whether Ajanta Pharma Ltd. Share Price sustains levels near Rs 3,722.15, along with valuation, sector comparison and peer profitability metrics. Those factors currently define the stock’s visible market context.